Abstract:OBJECTIVE:To compare the clinical characteristics and prognosis of acute graft-versus-host disease (aGVHD) between patients undergoing human leukocyte antigen (HLA)-identical and HLA-mismatched allogeneic hematopoietic stem cell transplantation (allo-HSCT).METHODS:Clinical data of 544 patients receiving related allo-HSCT in Institute of Hematology of Peking University from January 2010 to December 2011 were retrospectively analyzed. The clinical features of aGVHD including manifestations and prognosis between HLA-identical and HLA-mismatched transplantation were compared.RESULTS:The cumulative incidence of aGVHD in related HLA-mismatched transplant was 50.2%, which was significantly higher than that of HLA-identical transplant (20.4%, P < 0.001). However, the cumulative incidence of grade III°-IV° aGVHD between the two groups was comparable (4.5% vs 6.8%, P = 0.066). Gut aGVHD accounted for 31.1% in HLA-identical transplant while cutaneous aGVHD was the dominant area in HLA-mismatched transplant (66.5%). The incidence of gut and liver aGVHD in HLA-mismatched patients was also lower than that in HLA-identical patients. The proportion of patients with aGVHD accompanied by fever was higher in HLA-mismatched patients than in HLA-identical patients (47.6% vs 28.9%, P = 0.028). The cure rate of aGVHD in identical transplant was lower than that in mismatched transplant, especially for grade III°-IV° aGVHD. The complete remission rate after second-line anti-GVHD therapies was lower than that of mismatched transplant (88.9% vs 98.8%, P = 0.006). More patients died of aGVHD in identical transplant compared with mismatched transplant (11.1% vs 2.4%, P = 0.024).CONCLUSION:More patients who received HLA-mismatched allo-HSCT develop into aGVHD compared with HLA-identical transplant. But the incidence of severe aGVHD between HLA-identical and -mismatched is comparable. The overall cure rate of HLA-mismatched transplant is significantly higher than that of HLA-identical transplant.

[Exploration of Acute Graft Versus Host Disease and Its Risk Factors after Allo-Hematopoietic Stem Cell Transplantation].

[Analysis of Risk Factors for the Development of Acute Graft-Versus-host Disease in 151 Cases of Allo-Hematopoietic Stem Cell Transplantation].

[Graft Failure in Allogeneic Hematopoietic Stem Cell Trans-Plantation].

[Relationship of Tumor Necrosis Factor Gene Polymorphism and Acute Graft-Versus-host Disease after Unrelated Allogeneic Hematopoietic Stem Cell Transplantation].

Risk Factors for Acute Graft-Versus-Host Disease after Allogeneic Haematopoietic Stem Cell Transplantation: A Single-Center Experience.

[Effect of Graft-Versus-host Disease on Relapse and Survival in 100 Patients after Allogeneic Hematopoietic Stem Cell Transplantation].

Impairment of bone marrow endothelial progenitor cells in acute graft-versus-host disease patients after allotransplant.

Risk Factors for Graft-Versus-Host Disease After Transplantation of Hematopoietic Stem Cells from Unrelated Donors in the China Marrow Donor Program.

[Clinical Characteristics of Acute Graft-Versus-host Disease Confined Solely to Gastrointestinal Tract after Allogeneic Hematopoietic Stem Cell Transplantation].

Clinical characteristics of acute graft-versus-host disease among different donors of allogeneic hematopoietic stem cell transplantation.

Risk Factors Analysis for Steroid-Resistant Acute Graft Versus Host Disease after Haploidentical Hemato-Poietic Stem Cell Transplantation

A Comparison of Clinical Characteristics and Prognosis of Adult Acute Graft-Versus-host Disease Between Human Leukocyte Antigen-Identical And-Mismatched Allogeneic Hematopoietic Stem Cell Transplantation

Risk Factors for Chronic Graft-Versus-host Disease after Anti-Thymocyte Globulin-Based Haploidentical Hematopoietic Stem Cell Transplantation in Acute Myeloid Leukemia

Research on the Key T Cells and Cytokines of Agvhd after Allogeneic Hematopoietic Stem Cell Transplantation

Increased risk of nonrelapse mortality post T‐cell‐replete haploidentical stem cell transplantation in patients with recurrence of acute graft‐versus‐host disease

Associations between acute and chronic graft-versus-host disease

Cytokine expression during acute graft-versus-host disease after allogeneic peripheral stem cell transplantation

Proinflammatory cytokines as potential risk factors of acute graft-versus-host disease and infectious complications after allogeneic hematopoietic stem cell transplantation.

Prevalence of oral chronic graft versus host disease after allogeneic stem cell transplantation

Mortality, length of stay and costs associated with acute graft-versus-host disease during hospitalization for allogeneic hematopoietic stem cell transplantation

[Cytomegalovirus Diseases after Allogeneic Hematopoietic Stem Cell Transplantation (Allo-Hsct) and Related Risk Factors].